Abstract
The clinical and pathological manifestations of a case of juvenile GM1 gangliosidosis are presented and the pathological findings compared with those previously reported for GM1 gangliosidosis in man and in animal models. The most striking finding in the present case was the marked degeneration of the retinal ganglion cell and nerve fiber layers. Although such extensive ganglion cell loss was not observed in any of the other cases reviewed, the presence of multimembranous inclusion bodies in retinal ganglion cells strongly suggests that the pathological process was similar in all cases. Much remains to be learned about the function of gangliosides in the healthy retina and about the pathophysiological consequences of deranged ganglioside metabolism. The many parallels, including those observed in pathological studies, between the human and animal forms of GM1 gangliosidosis allow an optimistic appraisal of the value of further research using the animal models.
Similar content being viewed by others
References
Babarik A, Benson PF, Fensom AH, Barrie H (1976) Corneal clouding in GM1 generalized gangliosidosis. Br J Ophthalmol 60: 565–567
Baker HJ, Mole JA, Lindsey JR, Creel RM (1976) Animal models of human ganglioside storage diseases. Fed Proc 35: 1193–1201
Derry DM, Fawcett JS, Andermann F, Wolfe LS (1968) Late infantile systemic lipidosis: major monosialogangliosidosis: delineation of two types. Neurology 18: 340–348
Donnelly WJC, Sheahan BJ, Kelly M (1973a) Beta-galactosidase deficiency in GM1 gangliosidosis of Friesian calves. Res Vet Sci 15: 139–141
Donnelly WJC, Sheahan BJ, Rogers TA (1973b) GM1 gangliosidosis in Friesian calves. J Pathol 111: 173–179
Emery JM, Green WR, Wyllie RG, Howell RR (1971) GM1 gangliosidosis: ocular and pathological manifestations. Arch Ophthalmol 85: 177–187
Farrell DF, Mac Martin MP (1981) GM1 gangliosidosis: enzymatic reaction in a single family. Ann Neurol 9: 232–236
Farrell DF, Ochs U (1981) GM1 gangliosidosis: phenotypic variation in a single family. Ann Neurol 9: 225–231
Farrell DF, Baker HJ, Herndon RM, Lindsey JR, McKhann GM (1973) Feline GM1 gangliosidosis: biochemical and ultrastructural comparisons with the disease in man. J Neuropath Exp Neurol 32: 1–18
Feldges A, Müller HJ, Bühler E, Stalder G (1973) GM1 gangliosidosis. Part I. Clinical aspects and biochemistry. Helv Paediatr Acta 28: 511–519
Garner A (1973) Ocular pathology of GM2 gangliosidosis — type 2 (Sandhoff's disease). Br J Ophthalmol 57: 514–520
Gilbert EF, Varakis J, Opitz JM, Zu Rhein GM, Ware R, Viseskul C, Kaveggia EG, Hartmann HA (1975) Generalized gangliosidosis type II (juvenile GM1 gangliosidosis): a pathological, histochemical and ultrastructural study. Z Kinderheilkd 120: 151–180
Goebel HH, Fix JD, Zeman W (1973) Retinal pathology in GM1 gangliosidosis, type II. Am J Ophthalmol 75: 434–441
Goldman JE, Katz D, Rapin I, Purpura DP, Suzuki K (1981) Chronic GM1 gangliosidosis presenting as dystonia. I. Clinical and pathological features. Ann Neurol 9: 465–475
Gonatas NK, Gonatas J (1965) Ultrastructural and biochemical observations on a case of systemic late infantile lipidosis and its relationship to Tay-Sachs' disease and gargoylism. J Neuropathol Exp Neurol 24: 318–340
Hanna RB, Pappas GD, Purpura DP (1982) Freeze-fracture study of membranous cytoplasmic bodies of cortical neurons in feline GM1 ganglioside storage disease. Brain Res 252: 172–176
Harcourt RB, Dobbs RH (1968) Ultrastructure of the retina in Tay-Sachs' disease. Br J Ophthalmol 52: 898–902
Hooft C, Vlietinck RF, Dacremont G, Kint JA (1970) GM1 gangliosidosis Type II. Eur Neurol 4: 1–21
Lods F, Manassero J, Vaillaud JC, Kermarec J, Duplay H (1969) Lesions oculaires dans la gangliosidose generalisée de type GM1 (maladie de Landing). Bull Mem Soc Fr Ophthalmol 82: 479–490
Mamelle J-C, Vanier M-T, Baraton G, Gilly J, Carrier H, Guichard Y, Richard A, Gilly R (1975) Étude clinique, ultrastructurale et biochimique d'un cas de gangliosidose a GM1 de type 2. Arch Fr Pediatr 32: 925–940
Murray JA, Blakemore WF, Barnett KC (1977) Ocular lesions in cats with GM1 gangliosidosis with visceral involvement. J Small Anim Pract 18: 1–10
O'Brien JS (1975) Molecular genetics of GM1 β-galactosidase. Clin Genet 8: 303–313
O'Brien JS (1983) The Gangliosidosis. In: Stanbury JB, Wyngaarden JB, Fredrickson DS, Goldstein JL, Brown MS (eds). The metabolic basis of inherited disease. McGraw-Hill, New York, pp 950–957
O'Brien JS, Ho MW, Veath ML, Wilson JF, Myers G, Opitz JM, Zu Rhein GM, Spranger JW, Hartmann HA, Haneberg B, Grosse FR (1972) Juvenile GM1 gangliosidosis: Clinical, pathological, chemical, and enzymatic studies. Clin Genet 3: 411–434
O'Brien JS, Gugler E, Giedion A, Weissmann U, Herschkowitz N, Meier C, Leroy J (1976) Spondyloepiphyseal dysplasia, corneal clouding, normal intelligence and acid β-galactosidase deficiency. Clin Genet 9: 495–504
Patel V, Goebel HH, Watanabe I, Zeman W (1974) Studies on GM1 gangliosidosis, type II. Acta Neuropathol (Berl) 30: 155–173
Purpura DP, Baker HJ (1978a) Meganeurites and other aberrant processes of neurons in feline GM1 gangliosidosis: a Golgi study. Brain Res 143: 13–26
Purpura DP, Pappas GD, Baker HJ (1978b) Fine structure of meganeurites and secondary growth processes in feline GM1 gangliosidosis. Brain Res 143: 1–12
Read DH, Harrington DD, Keenan TW, Hinsman EJ (1976) Neuronal-visceral GM1 gangliosidosis in a dog with β-galactosidase deficiency. Science 194: 442–445
Rodriguez M, O'Brien JS, Garrett RS, Powell HC (1982) Canine GM1 gangliosidosis: an ultrastructural and biochemical study. J Neuropathol Exp Neurol 41: 618–629
Samuels S, Korey SR, Gonatas J, Terry RD, Weiss M (1963) Studies in Tay-Sachs' disease. J Neuropath Exp Neurol 22: 81–97
Seringe Ph, Dhermy P, Aron J-J (1969) Étude anatomo-clinique des lesions oculaires dues à la gangliosidose du type Norman-Landing a GM1. Ann Pediatr (Paris) 16: 748–755
Sheahan BJ, Donnelly WJC (1974) Enzyme histochemical and ultrastructural alterations in the brains of Friesian calves with GM1 gangliosidosis. Acta Neuropathol (Berl) 30: 73–84
Sheahan BJ, Donnelly WJC, Grimes TD (1978) Ocular pathology of bovine GM1 gangliosidosis. Acta Neuropathol (Berl) 41: 91–95
Singer HS, Coyle JT, Weaver DL, Kawamura N, Baker HJ (1982) Neurotransmitter chemistry in feline GM1 gangliosidosis: a model for human ganglioside storage disease. Ann Neurol 12: 37–41
Suzuki K, Suzuki K, Chen GC (1968a) Morphological, histochemical and biochemical studies on a case of systemic late infantile lipidosis (generalized gangliosidosis). J Neuropathol Exp Neurol 27: 15–38
Suzuki K, Suzuki K, Chen GC (1968b) GM1 gangliosidosis (generalized gangliosidosis): morphology and chemical pathology. Pathol Eur 3: 389–408
Suzuki K, Suzuki K, Kamoshita S (1969) Chemical pathology of GM1 gangliosidosis (generalized gangliosidosis). J Neuropathol Exp Neurol 28: 25–73
Taori GM, Basu DK, Chandi S, Raman PT, Abraham J, Leelavathy R, Job CK (1974) GM1 gangliosidosis. J Neurol Sci 21: 77–92
Wallace BJ, Volk BW, Schneck L, Kaplan H (1966) Fine structure localization of two hydrolytic enzymes in the cerebellum of children with lipidoses. J Neuropathol Exp Neurol 25: 76–96
Wenger DA, Sattler M, Mueller OT, Myers GG, Schneiman RS, Nixon GW (1980) Adult GM1 gangliosidosis: clinical and biochemical studies on two patients and comparison to other patients called variant or adult GM1 gangliosidosis. Clin Genet 17: 323–334
Wolfe LS, Senior RG, Ng Ying Kin NMK (1974) The structures of oligosaccharides accumulating in the liver of GM1-gangliosidosis, type I. J Biol Chem 249: 1828–1838
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cairns, L.J., Green, W.R. & Singer, H.S. GM1 Gangliosidosis, type 2: ocular clinicopathologic correlation. Graefe's Arch Clin Exp Ophthalmol 222, 51–62 (1984). https://doi.org/10.1007/BF02150632
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02150632